The Plasmaflo OP-05W(A) Asahi plasma separator is a medical device intended for
The Plasmaflo OP-05W(A) Asahi plasma separator is a medical device intended for the therapeutic separation of plasma from the whole blood in a clinical setting.
MDP
Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma
Intended for use in hemodialysis for the treatment of patients suffering from ac
Intended for use in hemodialysis for the treatment of patients suffering from acute or chronic renal failure.
KDI
Dialyzer, High Permeability With Or Without Sealed Dialysate System
Intended for use in hemodialysis for the treatment of patients suffering from ac
Intended for use in hemodialysis for the treatment of patients suffering from acute or chronic renal failure.
KDI
Dialyzer, High Permeability With Or Without Sealed Dialysate System
Intended for use in hemodialysis for the treatment of patients suffering from ac
Intended for use in hemodialysis for the treatment of patients suffering from acute or chronic renal failure.
KDI
Dialyzer, High Permeability With Or Without Sealed Dialysate System
The SeaStar CLR 2.0 hemofilter is indicated for use in patients with fluid overl
The SeaStar CLR 2.0 hemofilter is indicated for use in patients with fluid overload, uremia and/or electrolyte disturbances associated with oligoanuria acute renal failure. It may also be used when removal of excess fluid is indicated, such as patients in pulmonary edema or congestive heart failure refractory to diuretic therapy.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
For use with the Aquadex System. The Aquadex System is indicated for: Continuous
For use with the Aquadex System. The Aquadex System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
The Aquadex SmartFlow System is indicated for: Continuous ultrafiltration therap
The Aquadex SmartFlow System is indicated for: Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered within an outpatient or inpatient clinical setting by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration tr
The Aquadex System is indicated for temporary (up to 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.